Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Ventricular Arrhythmias in First Acute Myocardial Infarction: Epidemiology, Mechanisms, and Interventions in Large Animal Models

Publikation: Bidrag til tidsskriftReviewpeer review

DOI

  1. Women With Diabetes Are at Increased Relative Risk of Heart Failure Compared to Men: Insights From UK Biobank

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Transcatheter Bioprosthetic Aortic Valve Dysfunction: What We Know So Far

    Publikation: Bidrag til tidsskriftReviewpeer review

  4. BLTR1 and CD36 Expressing Microvesicles in Atherosclerotic Patients and Healthy Individuals

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Witnessed and unwitnessed sudden cardiac death: a nationwide study of persons aged 1-35 years

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Detection of atrial fibrillation with implantable loop recorders in horses

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Familial Evaluation in Idiopathic Ventricular Fibrillation: Diagnostic Yield and Significance of J-Wave Syndromes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Symptoms and healthcare contact preceding sudden cardiac death in persons aged 1-49 years

    Publikation: Bidrag til tidsskriftReviewpeer review

Vis graf over relationer

Ventricular arrhythmia and subsequent sudden cardiac death (SCD) due to acute myocardial infarction (AMI) is one of the most frequent causes of death in humans. Lethal ventricular arrhythmias like ventricular fibrillation (VF) prior to hospitalization have been reported to occur in more than 10% of all AMI cases and survival in these patients is poor. Identification of risk factors and mechanisms for VF following AMI as well as implementing new risk stratification models and therapeutic approaches is therefore an important step to reduce mortality in people with high cardiovascular risk. Studying spontaneous VF following AMI in humans is challenging as it often occurs unexpectedly in a low risk subgroup. Large animal models of AMI can help to bridge this knowledge gap and are utilized to investigate occurrence of arrhythmias, involved mechanisms and therapeutic options. Comparable anatomy and physiology allow for this translational approach. Through experimental focus, using state-of-the-art technologies, including refined electrical mapping equipment and novel pharmacological investigations, valuable insights into arrhythmia mechanisms and possible interventions for arrhythmia-induced SCD during the early phase of AMI are now beginning to emerge. This review describes large experimental animal models of AMI with focus on first AMI-associated ventricular arrhythmias. In this context, epidemiology of first AMI, arrhythmogenic mechanisms and various potential therapeutic pharmacological targets will be discussed.

OriginalsprogEngelsk
TidsskriftFrontiers in Cardiovascular Medicine
Vol/bind6
Sider (fra-til)158
ISSN2297-055X
DOI
StatusUdgivet - 2019

Bibliografisk note

Copyright © 2019 Sattler, Skibsbye, Linz, Lubberding, Tfelt-Hansen and Jespersen.

ID: 59124316